Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.06 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.091 | 0.07 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |